摘要
目的:观察补肾化瘀解毒中药对慢性特发性血小板减少性紫癜(ITP)和P-选择素影响,进而探讨中药疗效的作用机理,为临床用药提供依据。方法:将60例ITP患者随机分为2组,分别给予补肾化瘀解毒中药和泼尼松治疗,通过临床观察和对血浆蛋白C和P-选择素治疗前后的检测结果,分析补肾化瘀解毒中药对前述两项指标的影响。结果:两组患者治疗前后其血小板计数,均较治疗前有所增加(P<0.05),但两组间对照其差异无统计学意义(P>0.05)。两组治疗前后,其血浆蛋白C均有增高(P<0.01),P-选择素则有所降低(P<0.01)。结论:补肾化瘀解毒中药对ITP患者有较好疗效,其疗效与泼尼松相近,但却没有泼尼松之类激素的毒副作用。其治疗机理可能与有效有效调节的血浆蛋白C和P-选择素含量有关。
Objective: Studying the influence of invigorating the kidney and eliminating blood stasis and detoxifying therapeutics by TCM (IKESDT) on plasma protein C & P- Selectin for chronic idiopathic thrombocytopenlc purpura (ITP) patients, searching for its curative principle to provide clinic base. Method: Randomly dividing 60 ITP cases into two groups and treated with IKESDT herbs and prednisone respectively, detecting plasma protein C & P- Selectin before and after treatment. Result: Platelet count increases for two groups respectively after treatment (P<0.05), but there is no statistical difference between two groups(P>0.05). Plasma protein C increases for two groups respectively after treatment (P<0.01) while P- Selectin decreases (P<0.01). Conclusion: IKESDT herb has similar curative effect on ITP as prednisone, but without hormone-like side effect in prednisone. This effect may relate to its function to adjust plasma protein C & P- Selectin content.
出处
《成都中医药大学学报》
2003年第1期13-15,共3页
Journal of Chengdu University of Traditional Chinese Medicine
关键词
补肾化瘀解毒法
慢性特发性血小板减少性紫癜
ITP
血浆蛋白C
P-选择素
Invigorating the kidney and eliminating blood stasis and detoxifying therapeutics by TCM (IKESDT), ITP, plasma protein C, P- Selectin